📑49 Fourniture de medicaments ou autres produits du monopole pharmaceutique (med mn 1-2008) pour le CHU a Angers
Procurement process summary
This process is to purchase 49 Fourniture de medicaments ou autres produits du monopole pharmaceutique (med mn 1-2008) pour le CHU a Angers.
This contract was awarded by 🇫🇷 CHU d'Angers for an amount of EUR 7,308 to 1 supplier. It was published on 2008-07-17 through selective
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇫🇷 CHU d'Angers Buying unitnot reported Publication date2008-07-17 Contest statusnot reported DescriptionProduits pharmaceutiquesAwards
This award was granted to LILLY FRANCE,F-,92158 suresnes. by CHU d'Angers for an amount of EUR 7,308. The procurement process was conducted through selective for the category of Not available. This is award number 1.
| Supplier | Amount | Award number |
|---|---|---|
| 🇫🇷 LILLY FRANCE,F-,92158 suresnes. | EUR 7,308 | 1 |
Market context and opportunities
The execution of this contract allows the entity CHU d'Angers to fulfill its public service objectives efficiently.
The selective purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberFR_ocds-70d2nz-1765e79f-674d-4f93-986b-83ae95e15ca7-award-1Publication date2008-07-17Contract datenot reportedAward datenot reportedCategoriesPurchase modalityselectiveMethod detailsautre_negocieStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
